Methods for treatment of pulmonary disease using GM-CSF

Details Methods for treatment of pulmonary disease using GM-CSF Methods for treatment of pulmonary disease using GM-CSF

1998-03-20

2000-02-01

Mertz, Prema

Drug, bio-affecting and body treating compositions

Lymphokine

514 2, 514 8, 514 12, 514885, A61K 3819, A61K 912

Patent

active

060199652

ABSTRACT:
Methods of treatment of pulmonary disease, e.g., alveolar proteinosis, by treating a subject with an effective amount of GM-CSF.

REFERENCES:
patent: 5162111 (1992-11-01), Grabstein et al.
patent: 5545536 (1996-08-01), Kaushansky et al.
E. Stanley et al., The EMBO Journal, 4:2569-2573 (1985).
M. Tsuchiya et al., Eur. J. Biochem., 165:7-12 (1987).
S.L. Mansour et la., Nature, 336:349-352 (1988).
H. Tushida et al., Nature, 345:442-444 (1990).
H. Schorle et al., Nature, 352:621-624 (1991).
A. Bradley et al., Biotechnology, 10:534-539 (1992).
G. Dranuff et al., Science, 264;713-716 (1994).
J.A. Huffman et al., J. Clin. Invest., 97:649-655 (1996).
Lieschke et al., Clinical Oncology Society of Australia Inc., Annual Scientific Meeting. Abstract only.
Stedman's Medical Dictionary, 24.sup.th Ed. p. 1272.

Affiliated with

Also associated with

Rating

Methods for treatment of pulmonary disease using GM-CSF does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treatment of pulmonary disease using GM-CSF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treatment of pulmonary disease using GM-CSF will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-935134